Bibliography
- Kellum JA, Levin N, Bouman C, Lameire N. Developing a consensus classification system for acute renal failure. Curr Opin Crit Care 2002;8(6):509-14
- Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8(4):R204-12
- Chertow GM, Lazarus JM, Christiansen CL, et al. Preoperative renal risk stratification. Circulation 1997;95(4):878-84
- Chertow GM, Levy EM, Hammermeister KE, et al. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 1998;104(4):343-8
- Mangano CM, Diamondstone LS, Ramsay JG, et al. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 1998;128(3):194-203
- Conlon PJ, Stafford-Smith M, White WD, et al. Acute renal failure following cardiac surgery. Nephrol Dial Transplant 1999;14(5):1158-62
- Kuitunen A, Vento A, Suojaranta-Ylinen R, Pettila V. Acute renal failure after cardiac surgery: evaluation of the RIFLE classification. Ann Thorac Surg 2006;81(2):542-6
- Wijeysundera DN, Karkouti K, Beattie WS, et al. Improving the identification of patients at risk of postoperative renal failure after cardiac surgery. Anesthesiol 2006;104(1):65-72
- Boldt J, Kling D, Von Bormann B, et al. Blood conservation in cardiac operations. Cell separation versus hemofiltration. J Thorac Cardiovasc Surg 1989;97(6):832-40
- Boldt J, Zickmann B, Fedderson B, et al. Six different hemofiltration devices for blood conservation in cardiac surgery. Ann Thorac Surg 1991;51(5):747-53
- Koch CG, Li L, Duncan AI, et al. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg 2006;81(5):1650-7
- Koch CG, Li L, Duncan AI, et al. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med 2006;34(6):1608-16
- Kulier A, Levin J, Moser R, et al. Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery. Circulation 2007;116(5):471-9
- Karkouti K, Wijeysundera DN, Yau TM, et al. The influence of baseline hemoglobin concentration on tolerance of anemia in cardiac surgery. Transfusion 2008;48(4):666-72
- Karkouti K, Wijeysundera DN, Beattie WS. Risk associated with preoperative anemia in cardiac surgery: a multicenter cohort study. Circulation 2008; 117(4):478-84
- Koch CG, Li L, Sessler DI, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008;358(12):1229-39
- Habermann E, Arndts D, Just M, et al. [Behavior of Trasylol in the body as a model for the pharmacokinetics of basic polypeptides]. Med Welt 1973;24(29):1163-7
- Rustom R, Grime S, Maltby P, et al. A new method to measure renal tubular degradation of small filtered proteins in man using radiolabelled aprotinin (Trasylol). Clin Sci Colch 1992;83(3):289-94
- Rustom R, Jackson MJ, Critchley M, Bone JM. Tubular metabolism of aprotinin 99mTc and urinary ammonia: effects of proteinuria. Miner Electrolyte Metab 1992;18(2-5):108-12
- Rustom R, Grime JS, Maltby P, et al. Observations on the early renal uptake and later tubular metabolism of radiolabelled aprotinin (Trasylol) in man: theoretical and practical considerations. Clin Sci Colch 1993;84(2):231-5
- Rustom R, Grime JS, Maltby P, et al. Renal tubular protein degradation of radiolabelled aprotinin (Trasylol) in patients with chronic renal failure. Clin Sci Colch 1993;85(6):733-6
- Feindt PR, Walcher S, Volkmer I, et al. Effects of high-dose aprotinin on renal function in aortocoronary bypass grafting. Ann Thorac Surg 1995;60(4):1076-80
- Lemmer JH Jr, Stanford W, Bonney SL, et al. Aprotinin for coronary artery bypass grafting: effect on postoperative renal function. Ann Thorac Surg 1995;59(1):132-6 Issn: 0003-4975
- Vio CP, Oestreicher E, Olavarria V, et al. Cellular distribution of exogenous aprotinin in the rat kidney. Biol Chem 1998;379(10):1271-7
- Schweizer A, Hohn L, Morel DR, et al. Aprotinin does not impair renal haemodynamics and function after cardiac surgery. Br J Anaesth 2000;84(1):16-22
- Regoli D, Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol Rev 1980;32(1):1-46
- Porter GA, Bennett WM, Gilbert DN. Unraveling aminoglycoside nephrotoxicity using animal models. J Clin Pharmacol 1983;23(10):445-52
- Ulker S, Cinar MG, Bayraktutan U, Evinc A. Aprotinin impairs endothelium-dependent relaxation in rat aorta and inhibits nitric oxide release from rat coronary endothelial cells. Cardiovasc Res 2001;50(3):589-96
- Pfluger H, Maier M, Binder BR. Effects of antiproteases (aprotinin and gabexate-mesilate) on the postischemic vascular response of the kidney. Urol Int 1983;38(3):150-7 Issn: 0042-1138
- Kramer HJ, Dusing R, Glanzer K, et al. Effects of aprotinin on renal function. Contrib Nephrol 1984;42:233-41 Issn: 0302-5144
- Maier M, Starlinger M, Zhegu Z, et al. Effect of the protease inhibitor aprotinin on renal hemodynamics in the pig. Hypertension 1985;7(1):32-8 Issn: 0194-x0911
- Ozer Z, Sucu N, Dusmez D, et al. The effect of aprotinin on ischemia-reperfusion injury in the rabbit kidney. Pharmacol Res 2001;44(6):455-60
- Kher A, Meldrum KK, Hile KL, et al. Aprotinin improves kidney function and decreases tubular cell apoptosis and proapoptotic signaling after renal ischemia-reperfusion. J Thorac Cardiovasc Surg 2005;130(3):662-9
- Rustom R, Maltby P, Grime JS, et al. Effects of lysine infusion on the renal metabolism of aprotinin (Trasylol) in man. Clin Sci Colch 1992;83(3):295-9 Issn: 0143-5221
- O'connor CJ, Brown DV, Avramov M, et al. The impact of renal dysfunction on aprotinin pharmacokinetics during cardiopulmonary bypass. Anesth Analg 1999;89(5):1101-7
- Fauli A, Gomar C, Campistol JM, et al. Kidney-specific proteins in patients receiving aprotinin at high- and low-dose regimens during coronary artery bypass graft with cardiopulmonary bypass. Eur J Anaesthesiol 2005;22(9):666-71
- Available from: www.FDA.gov/ ohrms/dockets/AC/07/transcripts2007-4316T1-index.pdf
- Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992;38(10):1933-53
- Cockroft D, Gault M. Prediction of creatinine clearance from serum creatinne. Nephron 1976;16:31-41
- Tian S, Kusano E, Ohara T, et al. Cystatin C measurement and its practical use in patients with various renal diseases. Clin Nephrol 1997;48(2):104-8
- Mussap M, Dalla Vestra M, Fioretto P, et al. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int 2002;61(4):1453-61
- Page MK, Bukki J, Luppa P, Neumeier D. Clinical value of cystatin C determination. Clin Chim Acta 2000;297(1-2):67-72
- Blauhut B, Gross C, Necek S, et al. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass [see comments]. J Thorac Cardiovasc Surg 1991;101(6):958-67
- Levy JH, Pifarre R, Schaff HV, et al. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. Circulation 1995;92(8):2236-44
- Kertai MD, Varga KS, Royston D, et al. Aprotinin and perioperative complications in cardiac surgery. J Cardiovasc Surg (Torino) 2007;48(6):761-72
- Maslow AD, Chaudrey A, Bert A, et al. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid. J Cardiothorac Vasc Anesth 2008;22(1):6-15
- Mercieri M, Mercieri A, Tritapepe L, et al. High-dose aprotinin with gentamicin-vancomycin antibiotic prophylaxis increases blood concentrations of creatinine and cystatin C in patients undergoing coronary artery bypass grafting. Br J Anaesth 1999;82(4):531-6
- Ehrlich M, Grabenwoger M, Cartes Zumelzu F, et al. Operations on the thoracic aorta and hypothermic circulatory arrest: is aprotinin safe? J Thorac Cardiovasc Surg 1998;115(1):220-5
- Mora Mangano CT, Neville MJ, Hsu PH, et al. Aprotinin, blood loss, and renal dysfunction in deep hypothermic circulatory arrest. Circulation 2001;104(12 Suppl 1):I276-81
- Molenaar IQ, Begliomini B, Grazi GL, et al. The effect of aprotinin on renal function in orthotopic liver transplantation. EMSALT Study Group. European Multicenter Study on the Use of Aprotinin in Liver Transplantation. Transplantation 2001;71(2):247-52
- Wagener G, Gubitosa G, Wang S, et al. Increased Incidence of Acute Kidney Injury with Aprotinin Use during Cardiac Surgery Detected with Urinary NGAL. Am J Nephrol 2008;28(4):576-82
- Ling W, Zhaohui N, Ben H, et al. Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography. Nephron Clin Pract 2008;108(3):c176-81
- Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, et al. Neutrophil-gelatinase-associated lipocalin and renal function after percutaneous coronary interventions. Am J Nephrol 2006;26(3):287-92
- Vento M, Sastre J, Asensi MA, Vina J. Room-air resuscitation causes less damage to heart and kidney than 100% oxygen. Am J Respir Crit Care Med 2005;172(11):1393-8
- Mcbride WT, Allen S, Gormley SM, et al. Methylprednisolone favourably alters plasma and urinary cytokine homeostasis and subclinical renal injury at cardiac surgery. Cytokine 2004;27(2-3):81-9
- Morariu AM, Loef BG, Aarts LP, et al. Dexamethasone: benefit and prejudice for patients undergoing on-pump coronary artery bypass grafting: a study on myocardial, pulmonary, renal, intestinal, and hepatic injury. Chest 2005;128(4):2677-87
- Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006;354(4):353-65
- Karkouti K, Beattie WS, Dattilo KM, et al. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Transfusion 2006;46(3):327-38
- Ott E, Mazer CD, Tudor IC, et al. Coronary artery bypass graft surgery–care globalization: the impact of national care on fatal and nonfatal outcome. J Thorac Cardiovasc Surg 2007;133(5):1242-51
- Furnary AP, Wu Y, Hiratzka LF, et al. Aprotinin does not increase the risk of renal failure in cardiac surgery patients. Circulation 2007;116(11 Suppl):I127-33
- Shaw AD, Stafford-Smith M, White WD, et al. The effect of aprotinin on outcome after coronary-artery bypass grafting. N Engl J Med 2008;358(8):784-93
- Mouton R, Finch D, Davies I, et al. Effect of aprotinin on renal dysfunction in patients undergoing on-pump and off-pump cardiac surgery: a retrospective observational study. Lancet 2008;371(9611):475-82
- Kincaid EH, Ashburn DA, Hoyle JR, et al. Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery? Ann Thorac Surg 2005;80(4):1388-93
- Dietrich W, Busley R, Boulesteix AL. Effects of aprotinin dosage on renal function: an analysis of 8,548 cardiac surgical patients treated with different dosages of aprotinin. Anesthesiology 2008;108(2):189-98
- Pagano D, Howell NJ, Freemantle N, et al. Bleeding in cardiac surgery: the use of aprotinin does not affect survival. J Thorac Cardiovasc Surg 2008;135(3):495-502
- Royston D. Aprotinin; an economy of truth? J Thorac Cardiovasc Surg 2008;136(3):798-9
- Sedrakyan A, Treasure T, Elefteriades JA. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg 2004;128(3):442-8
- Brown JR, Birkmeyer NJ, O'connor GT. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. Circulation 2007;115(22):2801-13
- Henry DA, Carless PA, Moxey AJ, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2007;(4):CD001886
- Fergusson DA, Hebert PC, Mazer CD, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008;358(22):2319-31
- Marchetti J, Helou C, Chollet C, et al. ACE and non ACE mediated effect of angiotensin I on intracellular calcium mobilization in rat glomerular arterioles. Am J Physiol Heart Circ Physiol 2003;13:13
- Royston D. Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery? Ann Thorac Surg 2006;82(4):1575-6
- Royston D, Levy JH, Fitch J, et al. Full-dose aprotinin use in coronary artery bypass graft surgery: an analysis of perioperative pharmacotherapy and patient outcomes. Anesth Analg 2006;103(5):1082-8
- D'ambra MN, Akins CW, Blackstone EH, et al. Aprotinin in primary valve replacement and reconstruction: a multicenter, double-blind, placebo-controlled trial. J Thorac Cardiovasc Surg 1996;112(4):1081-9
- Sundt TD, Kouchoukos NT, Saffitz JE, et al. Renal dysfunction and intravascular coagulation with aprotinin and hypothermic circulatory arrest. Ann Thorac Surg 1993;55(6):1418-24
- Royston D. A case for aprotinin in patients having deep hypothermic circulatory arrest. J Card Surg 1997;12(2 Suppl):214-20
- Smith CR, Spanier TB. Aprotinin in deep hypothermic circulatory arrest. Ann Thorac Surg 1999;68(1):278-86
- Augoustides JG, Pochettino A, Ochroch EA, et al. Renal dysfunction after thoracic aortic surgery requiring deep hypothermic circulatory arrest: definition, incidence, and clinical predictors. J Cardiothorac Vasc Anesth 2006;20(5):673-7
- Goldstein DJ, Seldomridge JA, Chen JM, et al. Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality. Ann Thorac Surg 1995;59(5):1063-7
- Aronson S, Fontes ML, Miao Y, Mangano DT. Risk index for perioperative renal dysfunction/failure: critical dependence on pulse pressure hypertension. Circulation 2007;115(6):733-42
- Newsome BB, Warnock DG, McClellan WM, et al. Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction. Arch Intern Med 2008;168(6):609-16
- Latchamsetty R, Fang J, Kline-Rogers E, et al. Prognostic value of transient and sustained increase in in-hospital creatinine on outcomes of patients admitted with acute coronary syndrome. Am J Cardiol 2007;99(7):939-42